Advertisement
ADPT vs XGN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and XGN is a StrongBuy.
ADPT in downward trend: 10-day moving average broke below 50-day moving average on October 16, 2026
The 10-day moving average for ADPT crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ADPT moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 63 cases where ADPT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
ADPT moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
ADPT broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on ADPT as a result. In 77 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for ADPT just turned positive on October 27, 2026. Looking at past instances where ADPT's MACD turned positive, the stock continued to rise in 50 of 54 cases over the following month. The odds of a continued upward trend are 90%.
Following a +7.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in 236 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 170 of 188 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.985) is normal, around the industry mean (65.876). P/E Ratio (-62.650) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (13.966) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
XGN in upward trend: price rose above 50-day moving average on October 28, 2026
XGN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on XGN as a result. In 80 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for XGN just turned positive on October 29, 2026. Looking at past instances where XGN's MACD turned positive, the stock continued to rise in 31 of 36 cases over the following month. The odds of a continued upward trend are 86%.
The 10-day moving average for XGN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +11.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where XGN advanced for three days, in 190 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
XGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 155 of 185 cases where XGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
Bearish Trend Analysis
The 10-day RSI Indicator for XGN moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 28 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. XGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.638) is normal, around the industry mean (65.876). P/E Ratio (-10.232) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.592) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
ADPT | XGN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 22 Undervalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 99 | |
PRICE GROWTH RATING 1..100 | 37 | 34 | |
P/E GROWTH RATING 1..100 | 64 | 96 | |
SEASONALITY SCORE 1..100 | 25 | 32 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADPT's Valuation (22) in the Hospital Or Nursing Management industry is in the same range as XGN (38) in the null industry. This means that ADPT’s stock grew similarly to XGN’s over the last 12 months.
ADPT's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as XGN (100) in the null industry. This means that ADPT’s stock grew similarly to XGN’s over the last 12 months.
ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as XGN (99) in the null industry. This means that ADPT’s stock grew similarly to XGN’s over the last 12 months.
XGN's Price Growth Rating (34) in the null industry is in the same range as ADPT (37) in the Hospital Or Nursing Management industry. This means that XGN’s stock grew similarly to ADPT’s over the last 12 months.
ADPT's P/E Growth Rating (64) in the Hospital Or Nursing Management industry is in the same range as XGN (96) in the null industry. This means that ADPT’s stock grew similarly to XGN’s over the last 12 months.
| ADPT | XGN | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 77% | 7 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 89% |
| Advances ODDS (%) | 7 days ago 86% | 6 days ago 83% |
| Declines ODDS (%) | 2 days ago 85% | 2 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADPT’s FA Score shows that 1 FA rating(s) are green while XGN’s FA Score has 0 green FA rating(s).
- ADPT’s FA Score: 1 green, 4 red.
- XGN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADPT’s TA Score shows that 4 TA indicator(s) are bullish while XGN’s TA Score has 7 bullish TA indicator(s).
- ADPT’s TA Score: 4 bullish, 6 bearish.
- XGN’s TA Score: 7 bullish, 3 bearish.
Price Growth
ADPT (@Medical Specialties) experienced а -4.61% price change this week, while XGN (@Medical Specialties) price change was +12.32% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.34%. For the same industry, the average monthly price growth was -5.26%, and the average quarterly price growth was +42.07%.
Reported Earning Dates
ADPT is expected to report earnings on Nov 04, 2026.
XGN is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Medical Specialties (-2.34% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
XGN and
Correlation & Price change
A.I.dvisor tells us that XGN and SHC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and SHC's prices will move in lockstep.
| Ticker / NAME | Correlation To XGN | 1D Price Change % | ||
|---|---|---|---|---|
| XGN | 100% | -2.33% | ||
| SHC - XGN | 30% Poorly correlated | -2.26% | ||
| NTRA - XGN | 29% Poorly correlated | -8.54% | ||
| NEO - XGN | 27% Poorly correlated | -5.12% | ||
| ADPT - XGN | 26% Poorly correlated | -5.93% | ||
| QDEL - XGN | 26% Poorly correlated | +5.89% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FKU | 55.57 | 1.02 | +1.86% |
| First Trust United Kingdom AlphaDEX Fund (FKU) | |||
| DMO | 9.77 | 0.09 | +0.93% |
| Western Asset Mortgage Opportunity Fund | |||
| LFAI | 142.38 | N/A | N/A |
| LifeX 2050 Longevity Income ETF (LFAI) | |||
| QMOM | 69.62 | -1.38 | -1.94% |
| Alpha Architect U.S. Quantitative Momentum ETF (QMOM) | |||
| FENY | 36.89 | -1.59 | -4.13% |
| Fidelity MSCI Energy Index ETF (FENY) | |||